FDA Launches Regulatory Science Initiative with Personalized Rx Focus Areas
October 06, 2010
FDA Launches Regulatory Science Initiative with Personalized Rx Focus Areas
FDA has included personalized medicine among several research areas to which it plans to apply "the bulk" of its $25 million FY 2011 budget increase designated for regulatory science initiatives.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Q&A: CDRH's Gutierrez, Mansfield Discuss Ongoing Regulatory Efforts in Personalized Medicine
January 2, 2013 / Pharmacogenomics Reporter - Seeking 510(k) Clearance for Genomic Testing Service, 23andMe Maintains Direct-to-Consumer Ethos
August 1, 2012 / Pharmacogenomics Reporter - FDA Issues Draft Guidance on Pre-Submission Program to Help Device Makers Gain Early Agency Feedback
July 18, 2012 / Pharmacogenomics Reporter - Texas Congressman Drafts Bill to Keep Lab Test Oversight out of 'FDA's Lap,' Expand Authority of CMS
October 19, 2011 / Pharmacogenomics Reporter - FDA Outlines Regulatory Science Efforts for Medical Devices
October 5, 2011 / Pharmacogenomics Reporter